| Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of … GA Roth, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ... The lancet 392 (10159), 1736-1788, 2018 | 6942 | 2018 |
| Systematic review of levodopa dose equivalency reporting in Parkinson's disease CL Tomlinson, R Stowe, S Patel, C Rick, R Gray, CE Clarke Movement disorders 25 (15), 2649-2653, 2010 | 4227 | 2010 |
| The ENCODE (ENCyclopedia of DNA elements) project EA Feingold, PJ Good, MS Guyer, S Kamholz, L Liefer, K Wetterstrand, ... Science 306 (5696), 636-640, 2004 | 2390 | 2004 |
| Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990 … HH Kyu, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ... The Lancet 392 (10159), 1859-1922, 2018 | 2358 | 2018 |
| Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial A Williams, S Gill, T Varma, C Jenkinson, N Quinn, R Mitchell, R Scott, ... The Lancet Neurology 9 (6), 581-591, 2010 | 854 | 2010 |
| Physiotherapy versus placebo or no intervention in Parkinson's disease CL Tomlinson, S Patel, C Meek, CP Herd, CE Clarke, R Stowe, L Shah, ... Cochrane database of systematic reviews, 2013 | 708 | 2013 |
| Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study RA Evans, H McAuley, EM Harrison, A Shikotra, A Singapuri, M Sereno, ... The Lancet Respiratory Medicine 9 (11), 1275-1287, 2021 | 503 | 2021 |
| Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial MD Hill, M Goyal, BK Menon, RG Nogueira, RA McTaggart, AM Demchuk, ... The Lancet 395 (10227), 878-887, 2020 | 500 | 2020 |
| Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally … D Miles, J Gligorov, F André, D Cameron, A Schneeweiss, C Barrios, B Xu, ... Annals of Oncology 32 (8), 994-1004, 2021 | 472 | 2021 |
| Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open … PDMEDC Group Lancet 384 (9949), 1196-1205, 2014 | 433 | 2014 |
| Physiotherapy intervention in Parkinson’s disease: systematic review and meta-analysis CL Tomlinson, S Patel, C Meek, CP Herd, CE Clarke, R Stowe, L Shah, ... Bmj 345, 2012 | 424 | 2012 |
| Systematic review of role of bisphosphonates on skeletal morbidity in metastatic cancer JR Ross, Y Saunders, PM Edmonds, S Patel, KE Broadley, SRD Johnston Bmj 327 (7413), 469, 2003 | 388 | 2003 |
| Physiotherapy for Parkinson's disease: a comparison of techniques CL Tomlinson, CP Herd, CE Clarke, C Meek, S Patel, R Stowe, ... Cochrane Database of Systematic Reviews, 2014 | 375* | 2014 |
| Imaging features and safety and efficacy of endovascular stroke treatment: a meta-analysis of individual patient-level data L San Román, BK Menon, J Blasco, M Hernández-Pérez, A Dávalos, ... The Lancet Neurology 17 (10), 895-904, 2018 | 353 | 2018 |
| Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis … BCV Campbell, CBLM Majoie, GW Albers, BK Menon, N Yassi, G Sharma, ... The Lancet Neurology 18 (1), 46-55, 2019 | 335 | 2019 |
| The prevalence of joint contractures, pressure sores, painful shoulder, other pain, falls, and depression in the year after a severely disabling stroke C Sackley, N Brittle, S Patel, J Ellins, M Scott, C Wright, ME Dewey Stroke 39 (12), 3329-3334, 2008 | 323 | 2008 |
| Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10274), 605, 2021 | 322 | 2021 |
| Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study RA Evans, OC Leavy, M Richardson, O Elneima, HJC McAuley, ... The Lancet Respiratory Medicine 10 (8), 761-775, 2022 | 311 | 2022 |
| First-line atezolizumab plus nab-paclitaxel for unresectable, locally advanced, or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysis LA Emens, S Adams, CH Barrios, V Diéras, H Iwata, S Loi, HS Rugo, ... Annals of Oncology 32 (8), 983-993, 2021 | 310 | 2021 |
| Population and fertility by age and sex for 195 countries and territories, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017 CJL Murray, CSKH Callender, XR Kulikoff, V Srinivasan, D Abate, ... The Lancet 392 (10159), 1995-2051, 2018 | 303 | 2018 |
